The yield of final products was greatly improved by using a high concentration of megaprimers and asymmetric PCR. A PCR–based approach was developed that provides a powerful tool for engineering ...

Laura Bonetta reports. Real-time PCR combines the amplification of a DNA sequence with the detection of the amplified products during each reaction cycle—in other words, in real time.

Extension: Nucleotides are added to the primers, which serve as extension points to continue new strand synthesis. Endpoint analysis: Scientists analyze PCR products typically using agarose gel ...

Things haven’t got much better over the years, largely shutting STEM classes and biohackers out of the PCR market. That may be about to change, though, if the €99.00 PocketPCR thermal cycler ...

The PCR technologies market is expected to grow ... alongside higher public and private investments. By product segment, the market is segmented into reagents and consumables, which account ...

Robust sterility testing is essential to ensure the safety of cell therapies. However, traditional culture-based analysis takes several weeks to confirm a therapeutic’s microbial contamination, which ...

In terms of performance the PCR 56/06 EC SD includes S-curve, trapezoidal, velocity contouring, and electronic gearing profiles with position, velocity and torque control modes. Powered from 12 to 56V ...

Commercially available CE marked Aspergillus PCRs, such as Bruker’s Fungiplex Aspergillus, provide a standardised, validated, quality controlled product to meet customer needs. Fungiplex Aspergillus ...

The QX600™ Droplet Digital™ PCR System enables advanced six-color multiplexing, allowing clear discrimination of multiple targets with our extensive library of pre-optimized assays. The QX600 System ...

Berry Global's flexible films division has unveiled its new Bontite Sustane Stretch Film with 30% post-consumer recycled (PCR ...

Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to ...